ANTI-MARF Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.
Western Blotting (1 paper)

Allgemeine Beschreibung

Anti-Mitofusin 2 is produced in rabbit using as immunogen a synthetic peptide corresponding to human mitofusin 2 with an N-terminal added cysteine, conjugated to KLH. Mitofusins (Mfn1 and Mfn2) form homotypic and heterotypic complexes for fusion in mitochondria.

Biochem/physiol Actions

MFN2 is essential for the maintenance of mitochondrial network and controls mitochondrial metabolism. Mfn2-dependent regulatory mechanism is disturbed in obesity by reduced Mfn2 expression. Mutations in MFN2 cause Charcot Marie-Tooth neuropathy type 2A, a neurological disorder that results from degeneration of axons in peripheral nerves.

ANTI-MARF Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

ANTI-MARF Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Sigma-Aldrich	021-61415566 800-8193336	orderCN@merckgroup.com	China	51456	80
Merck KGaA	21-20338288	ordercn@merckgroup.com	China	292394	58

---

• Monoclonal Anti-Mitofusin 2 antibody produced in mouse
• Anti-MFN2 antibody produced in rabbit
• Anti-MFN2 (AB2) antibody produced in rabbit
• Anti-MFN2 (AB1) antibody produced in rabbit
• Monoclonal Anti-MFN2 antibody produced in mouse
• Anti-Mitofusin 2 antibody produced in rabbit
• Anti-Mitofusin-2 (N-Terminal) antibody produced in rabbit
• Anti-Mitofusin 2 (C-terminal) antibody produced in rabbit
• ANTI-CMT2A
• ANTI-CMT2A2
• ANTI-CPRP1
• ANTI-KIAA0214
• ANTI-MFN2
• ANTI-MITOFUSIN 2
• ANTI-MITOFUSIN-2 (N-TERMINAL)
• ANTI-MARF
• Anti-CMT2A2, Anti-CMT2A, Anti-CPRP1, Anti-KIAA0214, Anti-MARF, Anti-Mfn2
• Anti-Hyperplasia suppressor
• Anti-HSG
• Anti-Transmembrane GTPase MFN2
• Anti-Mitochondrial assembly regulatory factor